Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment

2013/01/08 by Frank Z. Stanczyk, David F. Archer, Bhagu R. Bhavnani · 4 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Estrogen and related hormone effects #Pregnancy and Medication Impact #Reproductive Health and Contraception

paper · doi:10.1016/j.contraception.2012.12.011

openalex publication_date 2013/01/08 · crossref created 2013/01/08 · crossref issued 2013/06/01 · crossref published 2013/06/01 · crossref published-print 2013/06/01 · crossref deposited 2025/09/14 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/23 · crossref indexed 2026/08/05

Citations

• Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
• Comparison of pharmacodynamic properties of various estrogen formulations
• Drug interactions between oral contraceptives and antibiotics
• Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis
• Pharmacokinetics and Pharmacodynamics of Conjugated Equine Estrogens: Chemistry and Metabolism
• Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study
• Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis
• Structure Activity Relationships and Differential Interactions and Functional Activity of Various Equine Estrogens Mediated via Estrogen Receptors (ERs) ERα and ERβ
• Pharmacokinetic and pharmacological features of oestradiol valerate
• International Union of Pharmacology. LXIV. Estrogen Receptors
• Oral contraceptive efficacy and antibiotic interaction: A myth debunked
• Cloning of a novel receptor expressed in rat prostate and ovary.
• Regulation of Ovarian Follicular Development in Primates: Facts and Hypotheses
• U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
• Hormonal contraception and risk of endometrial cancer: a systematic review
• Vascular Actions of Estrogens: Functional Implications
• 20 µg versus >20 µg estrogen combined oral contraceptives for contraception
• Non-contraceptive benefits of oral contraceptives

Cited by

• Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: A review of the data and identification of knowledge gaps
• Estrogen (medication) [wikipedia]
• Ethinylestradiol [wikipedia]
• Pharmacodynamics of estradiol [wikipedia]